Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome

Clinical trial NCT00815659 · COMPLETED

Trial details

NCT number: NCT00815659
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Syndrome

Start date: 2008-12-01
Primary completion: 2010-03-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.